Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study.
Corti N, Menzaghi B, Orofino G, Guastavigna M, Lagi F, Di Biagio A, Taramasso L, De Socio GV, Molteni C, Madeddu G, Salomoni E, Pellicanò GF, Pontali E, Bellagamba R, Celesia BM, Cascio A, Sarchi E, Gulminetti R, Calza L, Maggi P, Cenderello G, Bandera A, Carleo MA, Falasca K, Ferrara S, Martini S, Guadagnino G, Angioni G, Bargiacchi O, Ricci ED, Squillace N, Bonfanti P. Corti N, et al. Among authors: molteni c. Viruses. 2024 Apr 15;16(4):613. doi: 10.3390/v16040613. Viruses. 2024. PMID: 38675955 Free PMC article.
Reversibility of Central Nervous System Adverse Events in Course of Art.
Taramasso L, Orofino G, Ricci E, Menzaghi B, De Socio GV, Squillace N, Madeddu G, Vichi F, Celesia BM, Molteni C, Conti F, Del Puente F, Sarchi E, Angioni G, Cascio A, Grosso C, Parruti G, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: molteni c. Viruses. 2022 May 11;14(5):1028. doi: 10.3390/v14051028. Viruses. 2022. PMID: 35632768 Free PMC article.
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicanò G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: molteni c. BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y. BMC Infect Dis. 2022. PMID: 36151508 Free PMC article.
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.
Taramasso L, Falletta A, Ricci E, Orofino G, Squillace N, Menzaghi B, De Socio GV, Molteni C, Pellicanò GF, Gulminetti R, Madeddu G, Sarchi E, Vichi F, Celesia BM, Bonfanti P, Di Biagio A; CISAI Study Group. Taramasso L, et al. Among authors: molteni c. Viruses. 2022 Oct 22;14(11):2315. doi: 10.3390/v14112315. Viruses. 2022. PMID: 36366413 Free PMC article.
Incident diabetes in course of antiretroviral therapy.
Taramasso L, Squillace N, Ricci E, Menzaghi B, Orofino G, Socio GV, Molteni C, Martinelli CV, Madeddu G, Vichi F, Valsecchi L, Celesia BM, Maggi P, Rusconi S, Pellicanò GF, Cascio A, Sarchi E, Gulminetti R, Falasca K, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: molteni c. AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14. AIDS. 2023. PMID: 36927963
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study.
De Vito A, Ricci E, Menzaghi B, Orofino G, Martinelli CV, Squillace N, Taramasso L, De Socio GV, Molteni C, Valsecchi L, Costa C, Celesia BM, Parruti G, Pellicanò GF, Sarchi E, Cascio A, Cenderello G, Falasca K, Di Biagio A, Bonfanti P, Madeddu G. De Vito A, et al. Among authors: molteni c. Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720. Viruses. 2023. PMID: 36992429 Free PMC article.
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
Maggi P, Ricci ED, Cicalini S, Pellicanò GF, Celesia BM, Vichi F, Cascio A, Sarchi E, Orofino G, Squillace N, Madeddu G, De Socio GV, Bargiacchi O, Molteni C, Masiello A, Saracino A, Menzaghi B, Falasca K, Taramasso L, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: molteni c. BMC Infect Dis. 2023 Apr 14;23(1):227. doi: 10.1186/s12879-023-08191-2. BMC Infect Dis. 2023. PMID: 37059996 Free PMC article.
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.
Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, Masiello A, Orofino G, Menzaghi B, Bellagamba R, Vichi F, Celesia BM, Madeddu G, Pellicanò GF, Carleo MA, Cascio A, Parisini A, Taramasso L, Valsecchi L, Calza L, Rusconi S, Sarchi E, Martini S, Bargiacchi O, Falasca K, Cenderello G, Ferrara S, Di Biagio A, Bonfanti P; CISAI Study Group. Maggi P, et al. Among authors: molteni c. Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612. Viruses. 2023. PMID: 37515298 Free PMC article.
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: molteni c. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.
131 results